Nextcure, Inc. (NXTC) — 10-Q Filings

10-Q Filings (5)

• NextCure's Cash Dries Up, Raising Going Concern Doubts — Nov 5, 2025 Risk: high
  NextCure, Inc. reported a significant decline in its financial position for the nine months ended September 30, 2025. The company's cash and cash equivalents pl
• NextCure, Inc. Q1 2025 10-Q Filed — May 1, 2025 Risk: medium
  NextCure, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported total assets of $28,006,684 and total liabilities of $27,903,040 as of
• NextCure Reports Q3 2024 Results — Nov 7, 2024 Risk: medium
  NextCure, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported total assets of $279.8 million and total liabilities of $27.8 milli
• NextCure, Inc. Q2 2024 10-Q Filed — Aug 1, 2024 Risk: medium
  NextCure, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported financial results for the second quarter of 2024, detailing changes in i
• NextCure, Inc. Files 10-Q for Period Ending March 31, 2024 — May 2, 2024 Risk: low
  NextCure, Inc. (NXTC) filed a Quarterly Report (10-Q) with the SEC on May 2, 2024. NextCure, Inc. filed a 10-Q report for the period ending March 31, 2024. The

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX